REG - ConvaTec Group PLC - Director/PDMR Shareholding

ConvaTecAnnouncement

25/03/2022 14:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220325:nRSY1077Ga&default-theme=true

RNS Number : 1077G  ConvaTec Group PLC  25 March 2022

25 March 2022

ConvaTec Group Plc

("ConvaTec" or "the Company")

Director/PDMR Shareholding

The Company has been notified of the following transaction by a Person
Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence
each in the share capital of the Company ("Shares").

On 22 March 2022, Sharon O'Keefe, Non-Executive Director and PDMR, purchased
3,200 Shares, held as American Depositary Receipts (ADRs). Each ADR represents
four ordinary shares of 10 pence in the Company. Sharon O'Keefe's resulting
shareholding is 3,200 Shares.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Sharon O'Keefe
 2   Reason for the notification
 a)  Position/Status                                              Non-Executive Director
 b)  Initial notification/Amendment                               Initial notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         ConvaTec Group Plc
 b)  LEI                                                          213800LS272L4FIDOH92
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 10p each in ConvaTec Group Plc

     Identification code

                                                                  GB00BD3VFW73
 b)  Nature of the transaction                                    American Depositary Receipts (ADRs), each representing four ordinary shares of
                                                                  10p each in ConvaTec Group Plc

 c)  Price(s) and volume(s)                                       Price(s)                     Volume(s)

                                                                  $11.50                       800
 d)  Aggregated information

     - Aggregated volume                                          800

     - Price                                                      $9,200
 e)  Date of the transaction                                      2022-03-22
 f)  Place of the transaction                                     New York Stock Exchange (NYSE)

 

Enquiries

Analysts and Investors

Kate Postans, VP Investor Relations, ConvaTec
   +44 (0)782 644 7807

ir@convatec.com (mailto:ir@convatec.com)

 

Media

Buchanan: Charles Ryland / Chris Lane
               +44 (0)207 466 5000
 
 
 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on
solutions for the management of chronic conditions, with leading market
positions in advanced wound care, ostomy care, continence and critical care,
and infusion care. Our products provide a range of clinical and economic
benefits including infection prevention, protection of at-risk skin, improved
patient outcomes and reduced total cost of care. To learn more about ConvaTec,
please visit www.convatecgroup.com (http://www.convatecgroup.com/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFEVVSIEFIF